Skip to main content

Table 3 Influence of severity of symptoms in PedsQL™ Family Impact Module

From: The impact of severe rare chronic neurological disease in childhood on the quality of life of families—a study on MLD and PCH2

Sample

Total Impact Score

Parent HRQOL

Family Functioning

Gross motor

   

GMFC-MLD ≤ 4 (n = 10/10/10)

61.7 (18.6)

63.3 (19.6)

59.3 (19.6)

GMFC-MLD > 4 (n = 32/32/31)

56.5 (17.4)

60.6 (18.2)

47.3 (22.7)

Complete immobility

   

GMFC-MLD < 6 (n = 30/30/30)

61.8 (17.8)

64.2 (18.9)

56.0 (22.0)

GMFC-MLD = 6 (n = 12/12/11)

48.6* (13.5)

54.6 (15.8)

37.2* (18.3)

Speech

   

VSS < 4 (n = 10/10/10)

62.5 (16.8)

65.0 (18.0)

60.5 (17.8)

VSS = 4 (n = 32/32/31)

56.6 (17.9)

60.3 (18.6)

47.9 (23.2)

Complete loss of communication

   

VSS ≤ 4 (at least ability to express emotions) (n = 34/34/34)

61.5 (16.4)

65.1 (17.1)

54.3 (21.8)

No ability to express emotions (n = 8/8/7)

43.1** (15.3)

45.8** (15.9)

34.5 (19.3)

Visual stimulation

   

Visual stimuli perceptible (n = 32/32/32)

62.2 (16.7)

65.8 (17.2)

54.1 (21.5)

Visual stimuli not perceptible (n = 10/10/9)

44.8** (13.9)

47.4** (15.0)

39.6 (23.4)

Independent eating

   

Independent eating possible (n = 8/8/8)

66.3 (17.8)

67.7 (18.9)

64.5 (15.9)

No independent eating possible (n = 34/34/33)

56.1 (17.3)

60.0 (18.2)

47.7* (22.8)

PEG tube

   

No PEG tube present (n = 23/23/23)

62.7 (15.7)

64.8 (17.9)

56.4 (18.6)

PEG tube present (n = 19/19/18)

52.3* (18.5)

57.3 (18.6)

44.0 (24.5)

Final stage of disease

   

Child alive (n = 32/32/31)

61.7 (17.5)

64.7 (18.2)

55.4 (21.9)

Child deceased (n = 11/11/11)

44.5** (9.8)

49.3* (14.0)

34.2** (14.8)

  1. Standard deviation presented in parentheses. Different case numbers result from the fact that one Family Functioning scale was insufficiently completed. Higher values equal better functioning/less negative impact
  2. PedsQL™, Pediatric Quality of Life Inventory [23]; HRQOL, health-related quality of life; GMFC-MLD, Gross Motor Function Classification-MLD [16]; MLD, metachromatic leukodystrophy; VSS, The Viking Speech Scale [24]; PEG, percutaneous endoscopic gastrostomy
  3. *P value is significant at < 0.05 level; **P value is significant at < 0.01 level. Comparison between every pair of a sub-item